Aluminum Hydroxide
Showing 1 - 25 of 478
Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)
Recruiting
- Immune Response
- Keyhole-Limpet Hemocyanin
- +3 more
-
Oxford, United KingdomNIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023
HIV Trial in Boston (CH505 TF chTrimer, 3M-05-AF, Aluminum hydroxide suspension)
Active, not recruiting
- HIV Infections
- CH505 TF chTrimer
- +2 more
-
Boston, MassachusettsBrigham and Women's CRS
Jan 31, 2022
HIV Trial in New York, Philadelphia (gp145 C.6980 Vaccine, Placebo, Aluminum Hydroxide Adjuvant)
Completed
- HIV Infections
- gp145 C.6980 Vaccine
- +2 more
-
New York, New York
- +2 more
Oct 6, 2021
Healthy Trial in Leeds (Lu AG06466 Capsule, Lu AG06466 Tablet, Antacid)
Completed
- Healthy
- Lu AG06466 Capsule
- +2 more
-
Leeds, United KingdomLabCorp Clinical Research Unit Ltd
Jan 20, 2022
COVID-19 Trial in Peshawar (Medium-dosage COVID-19 Vaccine,Inactivated, High-dosage COVID-19 Vaccine,Inactivated,
Suspended
- COVID-19
- Medium-dosage COVID-19 Vaccine,Inactivated
- +2 more
-
Peshawar, PakistanCentral Park Teaching Hospital
Aug 9, 2022
Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine
Recruiting
- Hepatitis B
- GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
- +4 more
-
Cambridge, United KingdomGSK Investigational Site
Jan 12, 2023
COVID-19 (Healthy Volunteers) Trial in Korea, Republic of (GBP510 adjuvanted with Alum (RBD 10µg/dose) - Stage 1, Normal saline
Active, not recruiting
- COVID-19 (Healthy Volunteers)
- GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 1
- +5 more
-
Ansan, Korea, Republic of
- +11 more
May 9, 2022
HIV Trial (gp160 MN/LAI-2, Aluminum hydroxide)
Completed
- HIV Infections
- gp160 MN/LAI-2
- Aluminum hydroxide
- (no location specified)
Oct 13, 2021
HIV Trial in Rochester (HIV p17/p24:Ty-VLP, Aluminum hydroxide)
Completed
- HIV Infections
- HIV p17/p24:Ty-VLP
- Aluminum hydroxide
-
Rochester, New YorkUniv. of Rochester AVEG
Oct 28, 2021
Subarachnoid Hemorrhage, Brain Ischemia, Subarachnoid Hemorrhage, Aneurysmal Trial in Mexico City (Dapsone, Aluminum Hydroxide
Completed
- Subarachnoid Hemorrhage
- +5 more
- Dapsone
- Aluminum Hydroxide Gel
-
Mexico City, MexicoEl Instituto Nacional de Neurologia y Neurocirugia Manuel Velasc
Nov 10, 2021
HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)
Completed
- HIV Infections
- HIV Seronegativity
- Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
- +3 more
-
Baltimore, MarylandJHU AVEG
Oct 27, 2021
Human Immunodeficiency Virus Prevention, Human Immunodeficiency Virus (HIV) Trial run by the NIAID (VRC-HIVRGP096-00-VP, Alum
Completed
- Human Immunodeficiency Virus Prevention
- Human Immunodeficiency Virus (HIV)
- VRC-HIVRGP096-00-VP
- Alum Adjuvant
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 6, 2021
HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)
Completed
- HIV Infections
- Aluminum hydroxide
- +2 more
-
Saint Louis, Missouri
- +3 more
Oct 28, 2021
HIV Trial in Saint Louis, Rochester, Seattle (Aluminum hydroxide, Lipid A, Monophosphoryl, Lipid A, Liposome-encapsulated
Completed
- HIV Infections
- Aluminum hydroxide
- +7 more
-
Saint Louis, Missouri
- +2 more
Oct 28, 2021
HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)
Completed
- HIV Infections
- Aluminum hydroxide
- +2 more
-
Saint Louis, Missouri
- +4 more
Oct 28, 2021
HIV Trial in United States (Aluminum hydroxide, MF59, rgp120/HIV-1IIIB)
Completed
- HIV Infections
- Aluminum hydroxide
- +5 more
-
Los Angeles, California
- +9 more
Oct 27, 2021
Venezuelan Equine Encephalitis, Western Equine Encephalitis, Eastern Equine Encephalitis Trial in Decatur (VRC-WEVVLP073-00-VP,
Completed
- Venezuelan Equine Encephalitis
- +3 more
- VRC-WEVVLP073-00-VP
- VRC-GENMIX083-AL-VP
-
Decatur, GeorgiaThe Hope Clinic of the Emory Vaccine Center
Mar 23, 2021
Respiratory Syncytial Virus Trial run by the NIAID (VRC-RSVRGP084-00-VP, Aluminum Hydroxide Suspension)
Completed
- Respiratory Syncytial Virus
- VRC-RSVRGP084-00-VP
- Aluminum Hydroxide Suspension
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 21, 2020
Respiratory Tract Infection Trial in Worldwide (RSV vaccine, Placebo)
Completed
- Respiratory Tract Infection
- RSV vaccine
- Placebo
-
Birmingham, Alabama
- +158 more
Sep 20, 2022
Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)
HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine
Recruiting
- HIV Infections
- Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
- +3 more
-
Columbus, Ohio
- +1 more
Apr 10, 2022
Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster
Recruiting
- Vaccine-Preventable Diseases
- Herpes Zoster
- Recombinant Herpes Zoster Vaccine
- Recombinant Herpes Zoster Vaccine Placebo
-
Zhenjiang, Jiangsu, ChinaJiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023
Respiratory Syncytial Virus Trial in Halifax (DPX-RSV(A), RSV(A)-Alum, Placebo)
Completed
- Respiratory Syncytial Virus
- DPX-RSV(A)
- +2 more
-
Halifax, Nova Scotia, CanadaIWK Health Centre
Jan 31, 2020
Lyme Borreliosis, Nervous System Trial in La Mesa, Lincoln, Ghent (VLA15 with Alum, VLA15 without Alum)
Completed
- Lyme Borreliosis, Nervous System
- VLA15 with Alum
- VLA15 without Alum
-
La Mesa, California
- +2 more
Dec 16, 2022